2020
DOI: 10.1158/0008-5472.can-20-0506
|View full text |Cite
|
Sign up to set email alerts
|

Senescent Stromal Cells Promote Cancer Resistance through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles

Abstract: Improving the effectiveness of public health interventions relies as much on the attention paid to their design and feasibility as to their evaluation. Yet, compared to the vast literature on how to evaluate interventions, there is little to guide researchers or practitioners on how best to develop such interventions in practical, logical, evidence based ways to maximise likely effectiveness. Existing models for the development of public health interventions tend to have a strong social-psychological, individu… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
41
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 66 publications
(51 citation statements)
references
References 65 publications
1
41
0
Order By: Relevance
“…Several studies suggest that senescent stromal cells promote cancer resistance dependent on SIRT1 loss (49). Inhibiting SIRT1 by SMURF2 suppresses CRC cell proliferation(50).Our results suggest that miR-155 enhances the occurrence of autophagy through Sirt1 in liver cancer stem cells.Autophagy proved bene cial in evading various foreign pathogens in the context of cancer (51).…”
Section: Discussionsupporting
confidence: 53%
“…Several studies suggest that senescent stromal cells promote cancer resistance dependent on SIRT1 loss (49). Inhibiting SIRT1 by SMURF2 suppresses CRC cell proliferation(50).Our results suggest that miR-155 enhances the occurrence of autophagy through Sirt1 in liver cancer stem cells.Autophagy proved bene cial in evading various foreign pathogens in the context of cancer (51).…”
Section: Discussionsupporting
confidence: 53%
“…In senescent stromal cells, SIRT1-loss also causes impairment of lysosomes acidification and protein degradation. That is why senescent cells presumably prefer to release small extracellular vesicles into the tumor microenvironment, which enhances the aggressiveness and drug resistance of recipient cancer cells mediated by ATP binding cassette subfamily B member 4 (ABCB4) 115 .…”
Section: Sirt1 and Tumor Microenvironmentmentioning
confidence: 99%
“…Agents were delivered via i.p. once per biweekly starting from the beginning of the 3rd week, with totally three 2-week cycles throughout the whole regimen as reported formerly 16,17 .…”
Section: Hplc-qtof-msmentioning
confidence: 94%
“…We chose to employ a primary normal human prostate stromal cell line, namely PSC27, as a cell-based model for this purpose. Composed mainly of fibroblasts but with a minor percentage of non-fibroblast cell lineages including endothelial cells and smooth muscle cells, PSC27 is primary in nature and develops a typical SASP after exposure to stressors such as genotoxic chemotherapy or ionizing radiation [14][15][16][17] . We treated these cells with a pre-optimized sub-lethal dose of bleomycin (BLEO), and observed increased positivity for senescenceassociated β-galactosidase (SA-β-Gal) staining, decreased BrdU incorporation, and elevated DNA damage repair (DDR) foci several days afterwards (Supplementary Fig.…”
Section: Gse Restrains the Sasp Expression When Used At Low Concentrationsmentioning
confidence: 99%